BTIG Reiterates Buy Rating on MDxHealth SA (MDXH): "attractive small-cap growth and value stock"
Tweet Send to a Friend
BTIG analyst Mark Massaro reiterated a Buy rating and $7.00 price target on MDxHealth SA (NASDAQ: MDXH)The analyst commented, "MDx ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
